Mobile apps and study portals with CFR 21 Part 11 compliance, infrastructure, and process, developed specifically for the biopharma R&D organisation. Meet us at ISPOR in Boston to learn more about our mClinical Research software and consulting offerings.
Please pass by our Digital Health Outcomes booth #415 to speak about approaches to accelerating digital transformation in your organisation. Our team of experts will be presenting market access support platforms, interactive health economics models, value tools and other technology and design solutions for health economics, clinical and regulatory needs.
Apart from our core modelling, data and value story visualisation services and tools for Market Access and HEOR we will be presenting a set of new solutions for Electronic Data Capture and ePRO powered by mHealth apps.
Constant refinement of USP and value proposition is one of the main principles of modern marketing and it has found a reflection in Market Access too. It is important for pharmaceutical and medical devices companies to know their customers’ perceptions, needs and expectations. To meet and satisfy the demand for specific information or clinical evidence and to assign a fair market price in ever changing and evolving healthcare evidence and Real World Data (RWE).
Interested to learn more about interactive health data visualizations, digital tools and communication interfaces for HEOR models ?
We welcome ISPOR participants to meet us at our booth #512. We will be presentation our latest works, budget impact and cost-effectiveness models for iPad/Web, interactive health data visualizations and tools/platforms for value story delivery and communication.
Please come by our booth if you are interested to know more !
Digital Health Outcomes team
HEOR is a field of Economic Evaluations of Healthcare Technologies
Health Economics and Outcomes Research (HEOR) is an area of economic analyses that deals with the studies and mathematical models (simulations) based on available clinical, epidemiological, economic data and published evidence to inform rational and evidence based decision making. HEOR deals with allocation of funds for healthcare purchasing, evaluations of the value for money of healthcare technologies, drugs and medical devices in order to inform budgeting and change in clinical practice decisions. Healthcare payers (government, insurance companies, hospitals) operating under constrained budgets are always seeking to maximise the output (value, health, procedures) subject to limited financial resources and other constraints (technical, time, legal, management changes).
Pharma and medical devices companies put a lot of effort into development of their product value story. The value story often takes a form of an MS Excel file or a Power Point deck containing detailed information on burden of illness, product profile, clinical differentiators and health outcomes.
The question is – do these conventional document formats communicate product value story effectively ? Most probably not. With modern digital tools Key Account Managers (KAM) and Medical Science Liaisons (MSL) can present health data and evidence to payers and healthcare providers more effectively.
Modern ways of presenting evidence, data and models in an interactive digital format. Interested to learn more? Please join us at our booth #TT3 (Concourse Level) during ISPOR in DC.
We are keen to share our experience with the cutting edge data visualisation tools and latest web techs that maximise the impact of health economic models and value story. Our experts will be happy to answer any questions you might have regarding the choice of appropriate software techs, tools and data visualisation methods.
Check out our latest blog article on best practices to data visualisation and interactive storytelling: http://bit.ly/1OzbD8i
Looking forward to seeing you at the conference !
Digital Health Outcomes team
MS Excel, SAS, SPSS, R, Stata, Matlab and other statistics and modelling software packages are of great help when it comes to model core and logic development. These tools became available in mid eighties. They are around for 30 years already, but are they good enough for communication in modern digital era?
Presentation of health data is undergoing a big change, one that will influence not only how payers and providers make their decisions but also how pharma, medical devices and in-vitro diagnostics companies will interact with external world. Five years ago, interactive health data visualisations usually took a form of simple dashboards with animated charts and accompanying messages.
Nowadays evolutions of modern web capabilities and emergence of the powerful data visualisation tools open almost unlimited possibilities to visualise data and tell the complex story in an easy to digest manner.
Modern life is undoubtedly full of data and means to generate, present, receive or transfer it. It also implies that it has become much more difficult to filter useful and important pieces of information out of general “ocean” – distinguish significant from insignificant.
